TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36129720

Group type: EXPERIMENTAL
Intervention: Operative treatment with plate and screws
Number of subjects: 207

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Operative treatment (subgroup of mechanically ventilated patients)
Number of subjects: 207
Study: 32654580

Group type: EXPERIMENTAL
Intervention: OLNP-05
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33508690

Group type: EXPERIMENTAL
Intervention: Interim Buprenorphine Treatment (IBT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Waitlist Control (WLC)
Number of subjects: 16
Study: 34995935

Group type: EXPERIMENTAL
Intervention: L-arginine supplementation (10 g/day for 9 days)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 33256760

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 267

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 267
Study: 33470630

Group type: EXPERIMENTAL
Intervention: 4-tiered classification based on CT appearance and duration postsurgery; training group outcomes: I=10.5 d, II=24 d, III=66.5 d, IV=72 d; P=0.005.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 4-tiered classification; risk of salvage resection increased with grade 4 (risk ratio=9); P=0.043.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 4-tiered classification; complication severity increased; P=0.027.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Validation group outcomes; risk of salvage resection; P=0.007.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Validation group outcomes; hospital stay; P=0.001.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Validation group outcomes; complications; P=0.016.
Number of subjects: 59
Study: 33137517

Group type: EXPERIMENTAL
Intervention: ACUTENS
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 36168187

Group type: EXPERIMENTAL
Intervention: asciminib (40 mg twice-daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: bosutinib (500 mg once daily)
Number of subjects: 16
Study: 34661454

Group type: EXPERIMENTAL
Intervention: Ripretinib at a dose of 150 mg once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34383534

Group type: EXPERIMENTAL
Intervention: High dose methylphenidate (0.6 mg/kg/dose)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Low dose methylphenidate (0.3 mg/kg/dose)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Both doses of methylphenidate
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 32212340

Group type: EXPERIMENTAL
Intervention: R-lipoic acid (LA) 600 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: R,S-lipoic acid (LA) 1200 mg
Number of subjects: 20
Study: 35086075

Group type: EXPERIMENTAL
Intervention: Theta-low gamma (LG) phase amplitude coupling (PAC) during successful trials of the incongruent condition
Number of subjects: 8

Group type: COMPARATOR
Intervention: Group analysis of theta-LG PAC
Number of subjects: 8
Study: 32005419

Group type: EXPERIMENTAL
Intervention: Femaxeen
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 36038001

Group type: EXPERIMENTAL
Intervention: Continuous infusion of a balanced mixture of amino acids (2 g/kg ideal body weight/day)
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Placebo (balanced crystalloid solution)
Number of subjects: 3500
Study: 33561870

Group type: EXPERIMENTAL
Intervention: Preoperative opioid education
Number of subjects: 237

Group type: COMPARATOR
Intervention: No preoperative opioid education (Control)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Both groups (Preoperative education and Control)
Number of subjects: 237
Study: 35176163

Group type: EXPERIMENTAL
Intervention: Ribociclib plus docetaxel (docetaxel 60 mg/m2 every 21 days plus ribociclib 400 mg/day on days 1-4 and 8-15 with filgrastim on days 5-7)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Ribociclib plus docetaxel
Number of subjects: 43
Study: 33785752

Group type: EXPERIMENTAL
Intervention: 5-day fast followed by a modified Dietary Approach to Stop Hypertension diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Modified Dietary Approach to Stop Hypertension diet alone
Number of subjects: 0
Study: 32243049

Group type: EXPERIMENTAL
Intervention: Blepharoplasty with peeling (Phenol 89%)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blepharoplasty without peeling
Number of subjects: 30
Study: 34237809

Group type: EXPERIMENTAL
Intervention: Brazilian boys
Number of subjects: 2250

Group type: EXPERIMENTAL
Intervention: Brazilian girls
Number of subjects: 2250

Group type: EXPERIMENTAL
Intervention: Brazilian youth
Number of subjects: 2250
Study: 36478631

Group type: EXPERIMENTAL
Intervention: Modified simulated patient experience
Number of subjects: 127

Group type: COMPARATOR
Intervention: Video simulated learning
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Modified simulated patient as second activity
Number of subjects: 127

Group type: COMPARATOR
Intervention: Video learning as second activity
Number of subjects: 127
Study: 33398481

Group type: EXPERIMENTAL
Intervention: Arthroscopic management of femoroacetabular impingement (FAI)
Number of subjects: 154
Study: 35124742

Group type: EXPERIMENTAL
Intervention: Individual telephone-based extended-care
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Group telephone-based extended-care
Number of subjects: 410

Group type: COMPARATOR
Intervention: Educational control
Number of subjects: 410
Study: 34641819

Group type: EXPERIMENTAL
Intervention: Counselling sessions based on motivational interviewing (MI), 5 sessions during a 12-week outpatient pulmonary rehabilitation program.
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual-care control group (no counselling).
Number of subjects: 43
Study: 35038612

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g before skin incision and after placental delivery)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 110
Study: 35211291

Group type: EXPERIMENTAL
Intervention: Brace (n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional cast (n=30)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Brace (n=27)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional cast (n=27)
Number of subjects: 60
Study: 36314130

Group type: EXPERIMENTAL
Intervention: Multidisciplinary virtual HF intervention providing GDMT recommendations
Number of subjects: 91

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Multidisciplinary virtual HF intervention
Number of subjects: 91
Study: 33459692

Group type: EXPERIMENTAL
Intervention: Breathing exercises combined with dynamic upper- and lower-extremity exercises
Number of subjects: 26

Group type: COMPARATOR
Intervention: Dynamic upper- and lower-extremity exercises (Control)
Number of subjects: 26
Study: 34543829

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fusion Protein Inhibitor (FPI)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ibuprofen and FPI (combined therapy)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32447830

Group type: EXPERIMENTAL
Intervention: 650 usec 1064nm Nd:YAG laser
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study: 34051585

Group type: EXPERIMENTAL
Intervention: CuidaCare intervention (home-based, nurse-led intervention including cognitive restructuring, health education, and emotional support)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: CuidaCare intervention
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 224
Study: 35712291

Group type: EXPERIMENTAL
Intervention: Kinect-based interactive fall intervention system (40 min/session × 2 sessions/week × 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (maintained habitual activities)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Kinect-based interactive fall intervention system
Number of subjects: 30
Study: 34232005

Group type: EXPERIMENTAL
Intervention: HP/TAZ (halobetasol propionate 0.01% and tazarotene 0.045%) lotion, applied once daily for 8 weeks
Number of subjects: 418

Group type: COMPARATOR
Intervention: Vehicle lotion, applied once daily for 8 weeks
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: HP/TAZ
Number of subjects: 418
Study: 33888093

Group type: EXPERIMENTAL
Intervention: Claims-based definition of RA
Number of subjects: 334
Study: 32074798

Group type: EXPERIMENTAL
Intervention: Laparoscopic exploration combined with abdominal exfoliative cytology
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Intraperitoneal hyperthermic chemotherapy + conversion therapy
Number of subjects: 225
Study: 36007870

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP) therapy, 300 mL
Number of subjects: 421

Group type: COMPARATOR
Intervention: Control (non-CP)
Number of subjects: 421
Study: 33478335

Group type: EXPERIMENTAL
Intervention: VBN + EBUS
Number of subjects: 105

Group type: COMPARATOR
Intervention: EBUS
Number of subjects: 105
Study: 36241502

Group type: EXPERIMENTAL
Intervention: New-age music administered twice a day for 7 days postoperatively using headphones.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no music intervention).
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: New-age music intervention.
Number of subjects: 200
Study: 35466040

Group type: EXPERIMENTAL
Intervention: Food only
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Food plus water
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypohydration plus water
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hypohydration
Number of subjects: 30
Study: 32090516

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss intervention with a prescribed energy deficit of approximately 500 kcal/d
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Diet-induced weight loss intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Baseline comparison of miR-122-5p levels
Number of subjects: 85
Study: 36446694

Group type: EXPERIMENTAL
Intervention: Solution-Focused Approach (SFA)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 128
Study: 33205372

Group type: EXPERIMENTAL
Intervention: 0.01% atropine + spectacles (SA group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.01% atropine + OK lenses (OKA group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Spectacles only (S group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: OK lenses only (OK group)
Number of subjects: 80
Study: 35842583

Group type: EXPERIMENTAL
Intervention: Excimer laser ablation combined with drug-coated balloon (ELA + DCB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-coated balloon (DCB) alone
Number of subjects: 0
Study: 32877795

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy plus surgery (CRT + S group)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Surgery alone (S group)
Number of subjects: 411
Study: 35023049

Group type: EXPERIMENTAL
Intervention: Aerobic training for 16 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combined training (resistance and aerobic) for 8 weeks after 8 weeks of aerobic training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group performing low-intensity water-based therapeutic exercises
Number of subjects: 52
Study: 32131656

Group type: EXPERIMENTAL
Intervention: SWC + Dermalix (Dx)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Standard Wound Care (SWC)
Number of subjects: 48
Study: 35372632

Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil (2 drops, twice a day, for 4 consecutive days a week, for 4 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Almond oil (same dosage and duration as intervention)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Citrus aurantium essential oil
Number of subjects: 80
Study: 32892358

Group type: EXPERIMENTAL
Intervention: Receiving few likes during a standardized social media interaction
Number of subjects: 613

Group type: EXPERIMENTAL
Intervention: Receiving fewer likes
Number of subjects: 613
Study: 35915754

Group type: EXPERIMENTAL
Intervention: Outdoor running (OT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Treadmill running (TT)
Number of subjects: 28
Study: 34801353

Group type: EXPERIMENTAL
Intervention: Intense dose-dense epirubicin, paclitaxel, cyclophosphamide (iddEPC)
Number of subjects: 945

Group type: COMPARATOR
Intervention: Weekly paclitaxel, non-pegylated liposomal doxorubicin (plus carboplatin) (PM(Cb))
Number of subjects: 945
Study: 32112555

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT) combined with Skin-to-Skin Care (SSC)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Skin-to-Skin Care (SSC) alone
Number of subjects: 72
Study: 35788397

Group type: EXPERIMENTAL
Intervention: Passive self-ligating brackets
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Active self-ligating brackets
Number of subjects: 66

Group type: COMPARATOR
Intervention: Conventional brackets (control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 66
Study: 34179932

Group type: EXPERIMENTAL
Intervention: HP-HMB (Ensure® Plus Advance containing 3g HMB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (professional nutritional counselling for sufficient protein intake)
Number of subjects: 70
Study: 32235251

Group type: EXPERIMENTAL
Intervention: 27-gauge surgery
Number of subjects: 68

Group type: COMPARATOR
Intervention: 23-gauge surgery
Number of subjects: 68
Study: 35535555

Group type: EXPERIMENTAL
Intervention: Durvalumab plus FLOT chemotherapy
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Adjuvant durvalumab monotherapy
Number of subjects: 900

Group type: COMPARATOR
Intervention: Placebo plus FLOT chemotherapy
Number of subjects: 900
Study: 33571302

Group type: EXPERIMENTAL
Intervention: Housing First
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment As Usual
Number of subjects: 200
Study: 35572838

Group type: EXPERIMENTAL
Intervention: Submental island flap with psychological intervention
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Free flap with psychological intervention
Number of subjects: 180

Group type: COMPARATOR
Intervention: Routine nursing intervention (Control group C)
Number of subjects: 180
Study: 34401393

Group type: EXPERIMENTAL
Intervention: eLearning MHFA course
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Blended MHFA course
Number of subjects: 608

Group type: COMPARATOR
Intervention: Red Cross eLearning Provide First Aid (PFA) (control)
Number of subjects: 608
Study: 34436655

Group type: EXPERIMENTAL
Intervention: Massively parallel sequencing (MPS) using the PowerSeq 46Y kit (Promega)
Number of subjects: 247
Study: 32441786

Group type: EXPERIMENTAL
Intervention: Methylprednisolone treatment (n=18)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No methylprednisolone treatment (n=16)
Number of subjects: 34
Study: 34076349

Group type: EXPERIMENTAL
Intervention: Higher socioeconomic status (years of schooling, college or university degree, household income)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cigarettes smoked per day, time spent watching TV, polyunsaturated fatty acids, docosapentaenoic acid, eicosapentaenoic acid, arachidonic acid in blood
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum vitamin A1, copper in blood, docosahexaenoic acid in blood, body fat percentage
Number of subjects: 0
Study: 33989763

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation (109 CFU of 12 types of probiotics + fructooligosaccharides prebiotic), twice per day for 12 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo supplementation, twice per day for 12 weeks
Number of subjects: 69
Study: 32007393

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC) - four cycles of 5 min/5 min arm cuff inflation/deflation immediately prior to surgery
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 50
Study: 35746969

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over right inferior frontal cortex (rIFC) combined with cognitive training (CT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study: 34785365

Group type: EXPERIMENTAL
Intervention: Real M1‐rTMS treatment (10Hz, 10 daily treatments over 2 weeks)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 27
Study: 32643163

Group type: EXPERIMENTAL
Intervention: IMPaCT intervention (standardized community health worker intervention)
Number of subjects: 1340

Group type: EXPERIMENTAL
Intervention: IMPaCT intervention
Number of subjects: 1340

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1340
Study: 35685661

Group type: EXPERIMENTAL
Intervention: Berberine hydrochloride plus conventional treatment
Number of subjects: 68

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 68
Study: 33486392

Group type: EXPERIMENTAL
Intervention: Social Recovery Therapy (SRT) + Early intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) - early intervention care
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Social Recovery Therapy (SRT)
Number of subjects: 123
Study: 32074256

Group type: EXPERIMENTAL
Intervention: Standard care plus implantable loop recorder (ILR) with 24-hour Holter ECG monitoring (n = 17)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard care (24-hour Holter ECG monitoring) (n = 20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: ILR (n = 17)
Number of subjects: 40
Study: 35068440

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fine-needle puncture (USNP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Radial shock wave therapy (RSWT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Combined treatments (COMB)
Number of subjects: 62
Study: 33933014

Group type: EXPERIMENTAL
Intervention: Mindful movements
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Telemedicine programme
Number of subjects: 550

Group type: COMPARATOR
Intervention: Telemedicine
Number of subjects: 550
Study: 35313858

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 131

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Nitrates
Number of subjects: 131
Study: 33125033

Group type: EXPERIMENTAL
Intervention: OMT/VRT
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: OMT
Number of subjects: 23

Group type: COMPARATOR
Intervention: VRT
Number of subjects: 23
Study: 32583886

Group type: EXPERIMENTAL
Intervention: Lower achieved LDL-C in total, low, and high intensity statin users
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Middle tertile of matched baseline LDL-C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Highest tertile of matched baseline LDL-C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statin intensity
Number of subjects: 0
Study: 34528669

Group type: COMPARATOR
Intervention: Standard Treatment Group (targeted SBP <140 mm Hg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Intensive Treatment Group (targeted SBP <120 mm Hg)
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Low adherence
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: High adherence
Number of subjects: 9361

Group type: COMPARATOR
Intervention: MMAS-8 over time
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Primary outcome (composite of myocardial infarction, other acute coronary syndromes, stroke, heart failure, or death from cardiovascular causes)
Number of subjects: 9361
Study: 34250456

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (2.5, 5, or 10 µg) in a three-dose schedule on days 0, 28, and 56
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (5 µg) in a two-dose schedule on days 0 and 14/21/28
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Inactivated SARS-CoV-2 vaccine (10 µg) in a one-dose schedule
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Placebo (aluminum hydroxide adjuvant)
Number of subjects: 1120
Study: 34121635

Group type: EXPERIMENTAL
Intervention: Neural implantation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 40
Study: 34271286

Group type: EXPERIMENTAL
Intervention: hCPAP
Number of subjects: 224

Group type: COMPARATOR
Intervention: fCPAP
Number of subjects: 224
Study: 36237142

Group type: EXPERIMENTAL
Intervention: TNS A+ serum (topical growth factor serum), applied twice daily for 12 weeks
Number of subjects: 17
Study: 34613430

Group type: EXPERIMENTAL
Intervention: LSD (13 ?g)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: LSD (26 ?g)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33220010

Group type: EXPERIMENTAL
Intervention: DecoDisCo algorithm for distortion correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Multifrequency reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other distortion-correction approaches
Number of subjects: 0
Study: 35030040

Group type: EXPERIMENTAL
Intervention: Active PBMT
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo PBMT
Number of subjects: 50
Study: 33419444

Group type: EXPERIMENTAL
Intervention: Smartphone fundoscopy
Number of subjects: 146

Group type: COMPARATOR
Intervention: Non-mydriatic fundus camera
Number of subjects: 146

Group type: COMPARATOR
Intervention: Direct fundoscopy
Number of subjects: 146
Study: 33336360

Group type: EXPERIMENTAL
Intervention: Titrated oral misoprostol solution (OMS)
Number of subjects: 4395

Group type: COMPARATOR
Intervention: Vaginal dinoprostone
Number of subjects: 4395
Study: 32961319

Group type: EXPERIMENTAL
Intervention: NAVIFY Mutation Profiler
Number of subjects: 37
Study: 35102369

Group type: EXPERIMENTAL
Intervention: 25% ER high-nutrient-quality diet
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: 25% ER low-nutrient-quality diet
Number of subjects: 110

Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 110